82 related articles for article (PubMed ID: 24535606)
1. Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?
Derks JL; van Suylen RJ; Thunnissen E; den Bakker MA; Groen HJ; Smit EF; Damhuis RA; van den Broek EC; Speel EM; Dingemans AC;
Eur Respir J; 2017 Jun; 49(6):. PubMed ID: 28572122
[TBL] [Abstract][Full Text] [Related]
2. Correlation of cytidine deaminase polymorphisms and activity with clinical outcome in gemcitabine-/platinum-treated advanced non-small-cell lung cancer patients.
Tibaldi C; Giovannetti E; Tiseo M; Leon LG; D'Incecco A; Loosekoot N; Bartolotti M; Honeywell R; Cappuzzo F; Ardizzoni A; Peters GJ
Ann Oncol; 2012 Mar; 23(3):670-677. PubMed ID: 21652582
[TBL] [Abstract][Full Text] [Related]
3. Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer.
Li D; Frazier M; Evans DB; Hess KR; Crane CH; Jiao L; Abbruzzese JL
J Clin Oncol; 2006 Apr; 24(11):1720-8. PubMed ID: 16520463
[TBL] [Abstract][Full Text] [Related]
4. Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer.
Xu Y; Liu H; Liu S; Wang Y; Xie J; Stinchcombe TE; Su L; Zhang R; Christiani DC; Li W; Wei Q
Int J Cancer; 2018 Nov; 143(10):2400-2408. PubMed ID: 29978465
[TBL] [Abstract][Full Text] [Related]
5. Adding fasting-mimicking diet to first-line carboplatin-based chemotherapy is associated with better overall survival in advanced triple-negative breast cancer patients: A subanalysis of the NCT03340935 trial.
Ligorio F; Lobefaro R; Fucà G; Provenzano L; Zanenga L; Nasca V; Sposetti C; Salvadori G; Ficchì A; Franza A; Martinetti A; Sottotetti E; Formisano B; Depretto C; Scaperrotta G; Belfiore A; Vingiani A; Ferraris C; Pruneri G; de Braud F; Vernieri C
Int J Cancer; 2024 Jan; 154(1):114-123. PubMed ID: 37615485
[TBL] [Abstract][Full Text] [Related]
6. Incidence, Correlates, and Prognostic Significance of Mixed Response in Advanced Non-small Cell Lung Cancer.
Gerber DE; Wang Y; Ramalingam SS; Bhalla S; Sun Z; Borghaei H; Brahmer JR; Schiller JH
Oncologist; 2024 Apr; 29(4):342-349. PubMed ID: 38207008
[TBL] [Abstract][Full Text] [Related]
7. The prognostic values of CYP2B6 genetic polymorphisms and metastatic sites for advanced breast cancer patients treated with docetaxel and thiotepa.
Song Q; Zhou X; Yu J; Dong N; Wang X; Yang H; Ren J; Lyerly HK
Sci Rep; 2015 Nov; 5():16775. PubMed ID: 26602960
[TBL] [Abstract][Full Text] [Related]
8. Lipid Metabolism Pathway Genes and Lung Cancer: ACADSB rs12220683G>C Is Associated with Better Survival Outcome in Patients with Non-Small Cell Lung Cancer.
Yoo SS; Do SK; Choi JE; Kang HG; Hong MJ; Lee JH; Lee WK; Do YW; Lee EB; Park JE; Choi SH; Seo H; Lee YH; Lee J; Lee SY; Cha SI; Kim CH; Park JY
Oncology; 2024; 102(1):67-75. PubMed ID: 37527640
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomic study of gemcitabine efficacy in patients with metastatic pancreatic cancer: A multicenter, prospective, observational cohort study (GENESECT study).
Hatori M; Tsuji D; Suzuki K; Yokokawa T; Kawakami K; Moriyama R; Osada-Tsuchiya M; Otake A; Nakao M; Yano T; Arakawa Y; Matsuo K; Ohashi Y; Sakata Y; Kogure Y; Tamaki S; Wada A; Taki Y; Sasahira N; Ishii H; Yamaguchi M; Itoh K
Cancer; 2024 Apr; ():. PubMed ID: 38682652
[TBL] [Abstract][Full Text] [Related]
10. Equilibrative nucleotide transporter ENT3 (SLC29A3): A unique transporter for inherited disorders and cancers.
Ma H; Qu J; Liao Y; Liu L; Yan M; Wei Y; Xu W; Luo J; Dai Y; Pang Z; Qu Q
Exp Cell Res; 2024 Jan; 434(2):113892. PubMed ID: 38104646
[TBL] [Abstract][Full Text] [Related]
11. Auto Inflammatory Syndrome with SLC29A3 Mutation.
Jain A; Maheshwari A; Mahto D
Indian J Pediatr; 2023 Dec; ():. PubMed ID: 38114859
[No Abstract] [Full Text] [Related]
12. Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain.
Sisignano M; Baron R; Scholich K; Geisslinger G
Nat Rev Neurol; 2014 Dec; 10(12):694-707. PubMed ID: 25366108
[TBL] [Abstract][Full Text] [Related]
13. Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers.
Bharadwaj R; Jaiswal S; Velarde de la Cruz EE; Thakare RP
Diseases; 2024 Mar; 12(3):. PubMed ID: 38534987
[TBL] [Abstract][Full Text] [Related]
14.
Yoshihama T; Fukunaga K; Hirasawa A; Nomura H; Akahane T; Kataoka F; Yamagami W; Aoki D; Mushiroda T
Oncotarget; 2018 Jul; 9(51):29789-29800. PubMed ID: 30038720
[TBL] [Abstract][Full Text] [Related]
15. SLC3A2 is upregulated in human osteosarcoma and promotes tumor growth through the PI3K/Akt signaling pathway.
Zhu B; Cheng D; Hou L; Zhou S; Ying T; Yang Q
Oncol Rep; 2017 May; 37(5):2575-2582. PubMed ID: 28350098
[TBL] [Abstract][Full Text] [Related]
16. Equilibrative nucleoside transporters-A review.
Boswell-Casteel RC; Hays FA
Nucleosides Nucleotides Nucleic Acids; 2017 Jan; 36(1):7-30. PubMed ID: 27759477
[TBL] [Abstract][Full Text] [Related]
17. Genomic polymorphisms of SLC29A3 associated with overall survival in advanced non-small-cell lung cancer treated with gemcitabine.
Chen X; Zhang L; Ren S; Li X; Zhou F; Li W; Gao G; He Y; Zhou C
Med Oncol; 2014 Apr; 31(4):865. PubMed ID: 24535606
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D receptor genetic variants are associated with chemotherapy response and prognosis in patients with advanced non-small-cell lung cancer.
Xiong L; Cheng J; Gao J; Wang J; Liu X; Wang L
Clin Lung Cancer; 2013 Jul; 14(4):433-9. PubMed ID: 23522953
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of cyclooxygenase-2 gene polymorphisms in advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy.
Liu L; Zhou F; Ren S; Chen X; Li X; Li W; Zhou C
Asia Pac J Clin Oncol; 2016 Jun; 12(2):e339-46. PubMed ID: 25131817
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
